Boston Scientific Corp (NYSE:BSX) shares, rose in value on Thursday, December 12, with the stock price down by -0.15% to the previous day’s close as strong demand from buyers drove the stock to $90.42.
Actively observing the price movement in the last trading, the stock closed the session at $90.56, falling within a range of $90.32 and $91.37. The value of beta (5-year monthly) was 0.797 whereas the PE ratio was 74.79 over 12-month period. Referring to stock’s 52-week performance, its high was $91.93, and the low was $54.95. On the whole, BSX has fluctuated by 1.92% over the past month.
With the market capitalization of Boston Scientific Corp currently standing at about $133.26 billion, investors are eagerly awaiting this quarter’s results, scheduled for in January.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 16.59B, with a low estimate of 4.34B and a high estimate of 4.5B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.4B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BSX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 5.27, with the price of BSX currently trading nearly 0.46% and 3.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 57.10, while the 7-day volatility ratio is showing 1.48% which for the 30-day chart, stands at 1.67%. Furthermore, Boston Scientific Corp (BSX)’s beta value is 0.80, and its average true range (ATR) is 1.51.
A comparison of Boston Scientific Corp (BSX) with its peers suggests the former has fared considerably weaker in the market. BSX showed an intraday change of -0.15% in last session, and over the past year, it grew by 61.61%%.
Data on historical trading for Boston Scientific Corp (NYSE:BSX) indicates that the trading volumes over the past 10 days have averaged 3.75 and over the past 3 months, they’ve averaged 5.81 million. According to company’s latest data on outstanding shares, there are 1.47 billion shares outstanding.
Nearly 0.42% of Boston Scientific Corp’s shares belong to company insiders and institutional investors own 91.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.25 million shares as on 2024-11-29, resulting in a short ratio of 2.0. According to the data, the short interest in Boston Scientific Corp (BSX) stood at 83.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 12.91 million. The stock has risen by 56.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BSX stock heading into the next quarter.
